COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,233 Articles (22,733 medRxiv, 8,500 bioRxiv)

Most recent first Previous |  Page 283: Articles 2821-2830  | Next

Tracking SARS-CoV-2 variants of concern in wastewater: an assessment of nine computational tools using simulated genomic data
Sutcliffe, S. G., Kraemer, S. A., Ellmen, I., Knapp, J. J., Overton, A. K., Nash, D., Nissimov, J. I., Charles, T. C., Dreifuss, D., Topolsky, I., Baykal, P. I., Fuhrmann, L., Jablonski, K. P., Beerenwinkel, N., Levy, J. I., Olabode, A. S., Becker, D. G., Gugan, G., Britnell, E., Poon, A. F. Y., Valieris, R., Drummond, R. D., Defelicibus, A., Dias-Neto, E., Rosales, R. A., Tojal da Silva, I., Orfanou, A., Psomopoulos, F., Pechlivanis, N., Pipes, L., Chen, Z., Baaijens, J. A., Baym, M., Shapiro, B. J.
10.1101/2023.12.20.572426 — Posted: 2023-12-21
Deciphering Abnormal Platelet Subpopulations in Inflammatory Diseases through Machine Learning and Single-Cell Transcriptomics
Qiu, X., Nair, M. G., Jaroszewski, L., Godzik, A.
10.1101/2023.12.20.572680 — Posted: 2023-12-21
Persistence of an infectious form of SARS-CoV-2 post protease inhibitor treatment of permissive cells in vitro
Nair, M. S., Luck, M. I., Huang, Y., Sabo, Y., Ho, D. D.
10.1101/2023.12.20.572655 — Posted: 2023-12-21
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster
Marking, U., Bladh, O., Aguilera, K., Yang, Y., Greilert-Norin, N., Blom, K., Hober, S., Klingstrom, J., Havervall, S., Aberg, M., Sheward, D. J., Thalin, C.
10.1101/2023.12.21.572575 — Posted: 2023-12-21
Computational detection of antigen specific B cell receptors following immunization
Abbate, M. F., Dupic, T., Vigne, E., Shahsavarian, M. A., Walczak, A. M., Mora, T.
10.1101/2023.12.20.572660 — Posted: 2023-12-21
Using a decision tree to predict COVID case numbers: a tutorial for beginners
Moctezuma Tan, L., Benitez, L., van Nouhuijs, F., Orcales, F., Kim, A., Campbell, R., Fuse, M., Pennings, P. S.
10.1101/2023.12.19.572463 — Posted: 2023-12-20
Predictors of COVID-19 Vaccine Hesitancy in North-Central Nigeria.
Olutola, A., Gobir, I. B., Bazira, D., Agboola, S., Sanni, F. O., Nnadozie, H. O., Bello, A. A., Adamu, A., Bello, F., Otubo, S. A., Niyang, P. M.
10.1101/2023.12.20.23300316 — Posted: 2023-12-20
Distinct SARS-CoV-2 populational immune backgrounds induce divergent RBD evolutionary preferences
Ma, W., Fu, H., Jian, F., Cao, Y. R., Li, M.
10.1101/2023.12.19.572469 — Posted: 2023-12-20
Deep profiling of antigen-specific B cells from different pathogens identifies novel compartments in the IgG memory B cell and antibody-secreting cell lineages
Claireaux, M., Elias, G., Kerster, G., Kuijper, L. H., Duurland, M. C., Paul, A. G., Burger, J. A., Poniman, M., Olijhoek, W., de Jong, N., de Jongh, R., Wynberg, E., van Willigen, H. D., Prins, M., de Bree, G. J., de Jong, M. D., Kuijpers, T. W., Eftimov, F., van der Schoot, C. E., Rispens, T., Garcia-Vallejo, J. J., ten Brinke, A., van Gils, M. J., van Ham, S. M.
10.1101/2023.12.19.572339 — Posted: 2023-12-20
Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVID-19
Lee, J. T. H., Barnett, S. N., Roberts, K., Ashwin, H., Milross, L., Cho, J.-W., Huseynov, A., Woodhams, B., Aivazidis, A., Li, T., Majo, J., Guerrero, P. C., Lee, M., Miranda, A. M. A., Jablonska, Z., Arena, V., Hanley, B., Osborn, M., Uhlmann, V., Xu, X.-N., McLean, G. R., Teichmann, S. A., Randi, A. M., Filby, A., Kaye, P. M., Fisher, A. J., Hemberg, M., Noseda, M., Bayraktar, O. A.
10.1101/2023.12.20.572494 — Posted: 2023-12-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).